Model N survey shows 35% of US adults delay or skip prescriptions amid price uncertainty

Model N analysis found 35% of U.S. adults delayed, stretched, or skipped prescriptions due to unclear costs.

The survey showed 46% do not consistently know prescription prices before reaching the pharmacy, and 58% took cost-containment actions due to uncertainty.

Expected costs influenced treatment decisions for 46%, raising the risk of non-initiation, substitution, or dose rationing that can pressure branded-drug demand.

Price shopping increased: 72% checked prices using at least one method, and 40% said they are more likely to check than a year ago.

Stakeholder opacity persists: 76% had never heard of PBMs or did not know their role, complicating formulary-driven access strategies.